Long-term antibody persistence against hepatitis B in adolescents 14–15-years of age vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy-Reference-Cited by-同舟云学术

Long-term antibody persistence against hepatitis B in adolescents 14–15-years of age vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy

Published:2018-09-11 Issue:1 Volume:15 Page:235-241
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Schwarz Tino F.¹,Behre Ulrich²,Adelt Thomas³,Donner Matthias⁴,Suryakiran Pemmaraju V.⁵,Janssens Winnie⁶,Mesaros Narcisa⁶,Panzer Falko⁷

Affiliation:

1. Institute of Laboratory Medicine and Vaccination Centre, Klinikum Würzburg Mitte, Standort Juliusspital, Würzburg, Germany

2. Pediatric Practice, Kehl, Baden-Württemberg, Germany

3. Pediatric Practice, Bramsche, Germany

4. Pediatric Practice, Mönchengladbach, Germany

5. GSK, Bangalore, India

6. GSK, Wavre, Belgium

7. Pediatric Practice, Mannheim, Germany

Funder

GlaxoSmithKline Biologicals SA

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2018.1509658

Reference26 articles.

1. World Health Organization. Hepatitis B - fact sheet. 2017 Jul [accessed Jan 18]. http://www.who.int/mediacentre/factsheets/fs204/en/

2. World Health Organization. Regional Office for Europe. Immunization highlights 2015; [accessed Jan 18]. http://www.euro.who.int/__data/assets/pdf_file/0018/307620/Immunization-highlights-2015.pdf?ua=1.

3. European Centre for Disease Prevention and Control. Hepatitis B. In: ECDC. Annual epidemiological report for 2015. Stockholm: ECDC; 2017 [accessed Jan 18]. https://ecdc.europa.eu/sites/portal/files/documents/AER_for_2015-hepatitis-B.pdf.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of the Universal Implementation of Adolescent Hepatitis B Vaccination in Spain;Vaccines;2024-05-01

2. Prevalence of vaccine-derived hepatitis B surface antibodies in children and adolescents in Germany: results from a population-based survey, 2014–2017;BMC Infectious Diseases;2024-03-15

3. A systematic review reveals that African children of 15–17 years demonstrate low hepatitis B vaccine seroprotection rates;Scientific Reports;2023-12-13

4. Hepatitis B Vaccines;Plotkin's Vaccines;2023

5. Combination Vaccines;Plotkin's Vaccines;2023